Trius Therapeutics (TSRX): I don't know this stock all that well, said Cramer. I need to do some homework.
When Cramer does his homework I have a feeling he will endorse the stock. This is a significant issue.... too many investors don't know about TSRX and Tedizolid.....when they do this stock will be trading in the $15-$20 range. GL, longs. BTW, after he does his homework he will respond on his show. Let's Ride!!!
NO! He will call to arms his hedgefund friends on it with all their frontrunning! The peaceful little pond of promise here will have new subdivisions and bulldozers all around it! No more tiki bar, rafts, and slushy drinks! it will be investor acid indigestion and vats of pepto Bismol-----SSSSShhhhhhh!
You won;t get proper evolution of this PPS because they will game it all! They will nitpick at this data versus the competition which is established. You will hear the craziest garbage about this drug you ever thought possible if THEY get involved! SSShhhhhhhh!